EADV Congress 2023 Berlin
We thank each and every one who contributed to the overwhelming success of this year’s Congress. Featuring over 600 speakers from 50+ countries who conducted 180+ sessions, which drew an engaged audience of more than 15,500 delegates worldwide, your combined dedication has truly elevated this event to new heights.
BERLIN
11-14 OCTOBER 2023
Press releases and Scientific articles from the EADV Congress 2023
New research confirms link between perceived stress and psoriasis relapse
EADV Press Release Innovative research has provided compelling evidence that perceived stress can directly trigger the relapse of psoriatic skin
EADV 2023 Psoriasis Symposium Report
EADV 2023 Psoriasis Symposium Report: Advancing the Science and Management of Psoriasis and Psoriatic Arthritis
Study reveals significant stigma associated with female adult acne
EADV Press Release A new study presented today at the EADV Congress reveals the significant stigma associated with female adult
Delving deeper into the potential of AI
EADV Press Release New research, presented today at EADV Congress has revealed a significant improvement in skin cancer detection with
Almost half of patients with skin disease suffer from sleep disturbances, global study finds
EADV Press Release A global study presented at #EADVCongress shows that almost half of patients with skin disease suffer from
Non-melanoma skin cancer killing more people than melanoma, new study finds
EADV Press Release New research shows that non-melanoma skin cancer (NMSC) is now claiming more lives than melanoma, a more
Insulin resistance in acanthosis nigricans
Acanthosis nigricans is characterized by thickened velvety hyperpigmented plaques, most commonly the axilla, neck, and groin. Insulin and its receptors
Cutaneous adverse drug reactions in childhood
Cutaneous drug reactions in children may occur in various clinical patterns, ranging from mild maculopapular eruptions to severe conditions. Once
New developments in skin-directed treatments of cutaneous T-cell lymphoma
When treating the skin in patients with CTCL, we aim to minimize the extent of the cutaneous disease and reduce
JAK inhibitors for pruritus
In recent years, the pathophysiology of pruritus has been discovered in some conditions, including chronic prurigo and atopic dermatitis. Of
The expanding therapeutic pipeline of atopic dermatitis
Atopic dermatitis (AD) is a common skin disorder, characterized by a complex and heterogeneous pathogenesis that includes skin barrier dysfunction,
Low-dose oral minoxidil for androgenetic alopecia
(AGA) is a common form of hair loss affecting both men and women. Currently, the most widely used treatment for
New and emerging therapies for psoriasis
Climate change is one of the defining health threats of our time. Extreme heat directly interacts with dermatology, as the
From genetics to clinical care in dermatology: time to bring down the walls
Climate change is one of the defining health threats of our time. Extreme heat directly interacts with dermatology, as the
The impact of climate change on the skin
Climate change is one of the defining health threats of our time. Extreme heat directly interacts with dermatology, as the